-
Published on 24 Feb 2017
Feb.24
-- From tiny startups to global giants, the companies that sustain the
$324 billion U.S. biotech industry are increasingly alarmed as President
Donald Trump considers following his controversial travel ban with
restrictions on skilled foreign immigrants. Bloomberg's Doni Bloomfield
reports from the nation's biotech hub in Cambridge, Massachusetts.
No comments:
Post a Comment